Save your screen. Keep the bounds you have set, and get an email when an insider trades at a company it holds. A free account does both.
| Stock | FY | Clue Score ↓ | Market cap ↓ | Stock price ↓ | % change ↓ | PE ratio ↓ | Return on invested capital ↓ | Revenue growth 3Y ↓ | Net margin ↓ | Insider buyers 12M ↓ |
|---|---|---|---|---|---|---|---|---|---|---|
| TENXTENAX THERAPEUTICS, INC. | 2025 | 46 | $70.0M | $1.87 | +0.54% | — | -45.89% | — | — | 7 |